ANPATH GROUP, INC. ANNOUNCES INTRODUCTION OF EQUINETRU™

For Release:  Immediate

MOORESVILLE, NC (November 27, 2007) Anpath Group, Inc. (OTCBB: ANPG), reported today that its wholly-owned subsidiary, EnviroSystems, Inc. (ESI) announced the introduction of the initial product of an animal care product line based on its technology platform.

ESI stated that EquineTru™, an antiseptic treatment for skin and hoof conditions in horses, was introduced earlier this month at the Atlanta Fall Classic Horse Show held at the Georgia International Horse Park in Conyers, GA. The company is scheduled to introduce EquineTru™ to leading members of the United States Equestrian Federation, as well as, farriers, and veterinarians during November and December. Expanded product introduction and marketing efforts will begin early next year by targeting participants of the winter horse show season which kicks off in January.

The company plans to introduce a number of complimentary animal and pet care products designed to support the customer’s efforts to prevent and eliminate bacterial, fungal and viral infections on the animal and its environment. Initially, ESI has targeted the equine market. The American Horse Council reports the horse industry contributes more than $25 billion to the annual U.S. gross domestic product. There are more than 9 million horses in the U.S. and it is estimated that at any given time 1 of 10 horses suffers from either skin or hoof ailments.

EquineTru™ was developed to safely prevent and eliminate persistent and often debilitating skin and hoof ailments caused by micro-organisms. The active ingredient in EquineTru™, parachlorometaxylenol (PCMX) has been widely used as an antimicrobial in surgical hand and skin scrubs, antiseptics and disinfectants. It is also successfully used as a topical antiseptic for skin and mucous membranes, an antimicrobial in cosmetic formulations, and as a fungicide in a variety of applications. EquineTru™ has been reviewed and cleared for market by the Center for Veterinary Medicine (CVM) a division of the U.S. Food and Drug Administration (FDA).

Anpath Group, Incorporated:

Anpath Group, Inc., through its wholly-owned subsidiary EnviroSystems, Inc., produces cleaning and disinfecting products that it believes will help prevent the spread of infectious microorganisms while minimizing the harmful effects to people, equipment or the environment.

EnviroSystems, Inc. is focused on infection prevention technologies that the Company believes will position the Company in the forefront of the industry at a time when there is rapidly growing awareness of the critical need to prevent biological risks — both natural and man-made.

Forward Looking Statements:

This release contains forward-looking statements, which reflect expectation or belief by Anpath Group concerning future events that involve risks and uncertainties. Anpath Group can give no assurance that the expectations reflected in forward looking statements will prove correct and various factors could cause results to differ materially from Anpath Group expectations, including, but not limited to EPA registration of the Company’s products, the Company’s ability to carry out its business plan, successful development and commercial acceptance of its products, ability to fund development of its technology, the risk that products may not result from development activities, protection of its intellectual property, need for regulatory approvals, and other factors discussed in periodic Anpath Group filings with the Securities and Exchange Commission. Forward-looking statements are qualified in their entirety by the above cautionary statement. Anpath Group assumes no duty to update its outlook or other forward-looking statements as of any future date.

Contact Information:

J. Lloyd Breedlove
President & CEO
Anpath Group, Inc.
Phone:  704.658.3350
Email: jlbreedlove@envirosi.com
Website: www.anpathgroup.com